ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
CBD Life Sciences Inc (PK)

CBD Life Sciences Inc (PK) (CBDL)

0.0005
0.00
(0.00%)
Closed November 12 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0005
Bid
0.0004
Ask
0.0005
Volume
-
0.00 Day's Range 0.00
0.0001 52 Week Range 0.03
Previous Close
0.0005
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
28,027,630
Financial Volume
-
VWAP
-

CBDL Latest News

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market Projected to reach the $20 billion global...

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value The global CBD pet care...

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push With the potential for explosive profits in a $70 billion industry, CBDL's innovative...

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth Walmart's market cap as of...

CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement

CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement CBD Life Sciences propels its expansion with a major MOU, positioning the company...

CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products

CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products Leveraging Alibaba's 1.28 billion annual active consumers and $3...

CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 "Record-breaking revenue, new market entries, and transformative...

Firm Plans to Launch Vegan CBD Gummies Live on Amazon

With online marketplaces accounting for the majority of global sales, launching a product on one of the world’s largest selling platforms is sure to boost growth for this all-natural To read...

PURA Signals BUY After Farmersville Hemp Brand News

September 23, 2021 -- InvestorsHub NewsWire -- via pennymillions --  American Bulls Puration, Inc. (PURA) is reported today by American Bulls (americanbulls.com/PURA) to be signaling...

Seeking Alpha - CLNV Signs MOU Targeting $55 Billion Recycled Plastics Market

June 23, 2021 -- InvestorsHub NewsWire -- via Seeking Alpha Clean Vision's Subsidiary Clean-Seas Signs Binding MOU with Plastic Waste-to-Energy Technology Group Global Green Int'l...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0002-28.57142857140.00070.00070.0004609111250.00046342CS
4000.00050.00220.0004473800070.00074686CS
12-0.0002-28.57142857140.00070.00220.0004280276300.00071671CS
26-0.0057-91.9354838710.00620.022410.0004161862480.00077738CS
52-0.0295-98.33333333330.030.030.0001123329390.00526943CS
156-0.0895-99.44444444440.090.090.0001426281420.0547232CS
260-1.0495-99.95238095241.0560.00011219611590.3302625CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.03325
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0269
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.03325
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0269
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
BRDCYBridgestone Corp (PK)
$ 17.70
(0.00%)
1.68M
TBVPFThai Beverage Public Co Ltd (PK)
$ 0.3514
(0.00%)
1.27M
LTSRFLotus Resources Ltd (QX)
$ 0.1622
(0.00%)
404k
ELVUFElevate Uranium Ltd (QX)
$ 0.1825
(0.00%)
225k
FMCKJFederal Home Loan Mortgage Corporation (QB)
$ 9.65
(0.00%)
200.8k

CBDL Discussion

View Posts
packerfan9 packerfan9 4 days ago
Just like the past. Have on day of big volume that caused a short spike in price. Then as the company keeps diluting. Down it goes. Maybe it could pop one more time but doubtful as massive dilution. Spare me the no dilution. All the same said before. Then financials will show it is billions. Just like the past.
๐Ÿ‘๏ธ0
packerfan9 packerfan9 5 days ago
They never say on Pr's what revenues are now or gong to be. Last income statement showed 167,000. Billions in dilution. Even if they did 1 million. It's over valued. A big if considering all the places selling cbd products. They are a no body and revenues show that. It's why they get rich selling billions of shares not products. Same bs as always with them.
๐Ÿ‘๏ธ0
packerfan9 packerfan9 5 days ago
Maybe like before but will neve last long. Just too much dilution. By the time they sell all 4.5 billion shares. Same as before .00001 and stuck until next rs. To ignore the past is to be another shareholder stuck at .00001. All before this r.s were and lost.
👍️ 1 🤑 1
AveragePenny AveragePenny 5 days ago
$CBDL CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling


https://www.accesswire.com/939772/cbd-life-sciences-inc-cbdl-positioned-for-unmatched-growth-as-trump-welcomes-weed-legalization-and-federal-rescheduling

The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD 57.18 billion in 2023 to USD 444.34 billion by 2030, exhibiting a CAGR of 34.03% during the forecast period. North America dominated the global market with a share of 81.79% in 2022.

SCOTTSDALE, AZ / ACCESSWIRE / November 7, 2024 / With Former President Donald Trump's recent support for cannabis legalization in key U.S. states and calls to reclassify cannabis as a Schedule III drug, CBD Life Sciences, Inc. (OTC PINK:CBDL) is primed to accelerate its growth in the rapidly expanding cannabis and CBD market. This evolving regulatory environment is expected to unlock powerful revenue streams for CBDL, giving the company a strong competitive edge in an industry poised to reach unprecedented heights.

Major Market Opportunity: Riding the $100 Billion Wave

The U.S. cannabis market is projected to exceed $100 billion by 2030, fueled by widespread voter and legislative support. Trump's endorsement, including a personal commitment to vote "yes" on Florida's Amendment 3 to legalize recreational cannabis, signals bipartisan momentum for cannabis acceptance-a shift that could propel federal rescheduling and facilitate financial growth opportunities across the industry. As cannabis becomes more accessible, CBDL is strategically positioned to deliver innovative products that appeal to a broad consumer base, from wellness enthusiasts to medical patients.

CEO Lisa Nelson: "CBDL Ready to Capture Expansive Market Growth"

"For CBDL, this is a historic moment particularly as the company is currently in a Letter of Intent (LOI) with a cannabis dispensary, positioning itself to capitalize on the growing wave of cannabis legalization." says CEO Lisa Nelson. "With Trump having such significant support from both the public and key political leaders, the market potential is staggering. CBDL's strategic growth plan is designed to capture both the economic impact of increased accessibility and the opportunity to reach millions of new customers nationwide." This moment is especially historic as CBDL is currently in the middle of a Letter of Intent (LOI) with a cannabis dispensary, which aligns perfectly with this new wave of support for cannabis legalization."

CBDL's approach includes product innovation focused on high-quality CBD and cannabis-infused offerings tailored to meet the diverse needs of consumers. As more states pass cannabis-friendly laws, CBDL's distribution channels will expand, enabling the company to maximize its reach in high-demand markets and set new revenue records.

Unlocking Financial Pathways and Reducing Market Barriers

Rescheduling cannabis would not only open more avenues for scientific research but also allow CBD companies like CBDL to benefit from traditional financial and banking services. This anticipated regulatory easing means lower costs, streamlined operations, and increased scalability for CBDL-each of which has a direct impact on shareholder value and revenue growth. With a supportive regulatory environment, CBDL is expected to experience accelerated revenue increases, while establishing a reputation as a leader in research-backed, health-focused cannabis products.

Growing Market Support and Consumer Demand

CBDL's market expansion is also driven by strong consumer support: a recent Pew Research survey revealed that 88% of Americans favor cannabis legalization for either medical or recreational use, with 42% seeing it as a step toward a fairer criminal justice system. This shifting public opinion reflects a robust and growing market, allowing CBDL to target both new and existing consumers across recreational, medical, and wellness sectors. By leveraging this unprecedented demand, CBDL is well-positioned to introduce unique products to fulfill evolving consumer preferences and capitalize on the high-growth potential in this industry.

Link to Article: https://www.usatoday.com/story/news/politics/2024/11/05/donald-trump-marijuana-weed-cannabis-legalization-medical-recreational-election/75970501007/
๐Ÿ‘๏ธ0
konshe konshe 6 days ago
Can you linked here?
🙄 1 🤔 1
konshe konshe 6 days ago
ready to take off again.
👍️ 1 🤑 1
koolmc koolmc 7 days ago
they tweeted that today?
๐Ÿ‘๏ธ0
MahinAgency MahinAgency 7 days ago
OTCMKTS: $CBDL BIG NEWS COMING

$CBDL close in getting the Armed Forces deal closed. Our product of the horse paste is taking off! Walmart orders are shipping out the door. More news coming Stay tuned
👍️ 1
MahinAgency MahinAgency 7 days ago
OTCMKTS: $CBDL close in getting the Armed Forces deal closed. CBD Life Sciences Ord Shs product of the horse paste is taking off! Walmart orders are shipping out the door
👍️ 1
packerfan9 packerfan9 7 days ago
Yes. Safe to say nothing changed here. Massive dilution again.
๐Ÿ‘๏ธ0
delerious1 delerious1 1 week ago
So safe to say you missed the latest pop❓️
๐Ÿ‘๏ธ0
packerfan9 packerfan9 1 week ago
The only way to make money here is doing that. What I have seen though. Doing it one time too many as it drops to .00001 and done. The dilution here has never ended and never will. The revenues after 4 years so tiny vs the billions and billions in dilution. Nothing has changed here. All the same posts telling me same things as before. All were wrong. Good luck timing this. As selling always competes with dilution selling.
๐Ÿ‘๏ธ0
konshe konshe 1 week ago
I don't care dilution or not, I just do buy low and sell high. I re buy in at 0.0006, will sell after 0.001.
๐Ÿ‘๏ธ0
konshe konshe 1 week ago
Only OTCN is dilution MM?
๐Ÿ‘๏ธ0
Big RDC Big RDC 1 week ago
I think Harris is more pro on Cannabis and CBD then Trump
๐Ÿ‘๏ธ0
SmellMyFinger SmellMyFinger 1 week ago
Feel free to explain your rationale, but please, keep it on topic regarding $CBDL.
👍️ 1
Big RDC Big RDC 1 week ago
If Harris wins we run hard if not we hit .0001 My take on it.
👍️ 1 💫 1
packerfan9 packerfan9 2 weeks ago
Every time they increase the A/s to billions. People argue they are not diluting. Every time wrong. Nothing has changed. Look at price after the r/s. No one had 100's of millions of shares to sell. Know who has billions to sell yet again. The company. All this is another repeat of the same thing. The revenues are so tiny. The o/s used to be over 40 billion. Nothing can justify billions sold when revenues under 200K. Even if they can ever sell millions in sales. A long way from that. They still make more selling shares. Ignore the track record and lose. Like many have thinking they would grow big revenues. CBD is a very competitive market. They will never sell enough to justify what they have done to shareholders.
๐Ÿ‘๏ธ0
koolmc koolmc 2 weeks ago
otcn on ask
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
Donโ€™t know. Some people are saying theyโ€™re diluting
👍️ 1
delerious1 delerious1 2 weeks ago
I tried to get in this one last week and been away for a few days but I saw it rocketing...so what caused it to drop again, was it news or just the normal correction?
๐Ÿ‘๏ธ0
resx18 resx18 2 weeks ago
#PowerHour $CBDL
๐Ÿ‘๏ธ0
MahinAgency MahinAgency 2 weeks ago
$CBDL Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
The bid is huge compared to the ask
๐Ÿ‘๏ธ0
MahinAgency MahinAgency 2 weeks ago
OTCMKTS: $CBDL CBD Life Sciences Inc. is entering the CBD equine market, projected to grow at 40.3% CAGR through 2028, to capture demand in this high-growth, low-competition sector.
๐Ÿ‘๏ธ0
konshe konshe 2 weeks ago
I don't think dilution now, O/S shares didn't increasing recently. I am ready to get in again, because business is going ahead and has good future. 0.0006 is a good buy if you can get.
๐Ÿ‘๏ธ0
 stock king 1 stock king 1 2 weeks ago
Imho when the real share count comes out , it might get close to 3 billionโ€ฆ
๐Ÿ‘๏ธ0
resx18 resx18 2 weeks ago
Just starting! Did you grab any 6's or 7's ? $CBDL
๐Ÿ‘๏ธ0
 stock king 1 stock king 1 2 weeks ago
It was a hell of a pump and dump
๐Ÿ‘๏ธ0
resx18 resx18 2 weeks ago
$CBDL in the loading zone !!!!!!!
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
Good morning
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
Unfortunately buyers donโ€™t think itโ€™s huge. Now back to .0006
๐Ÿ‘๏ธ0
konshe konshe 2 weeks ago
not too much sell at 0.0006?
๐Ÿ‘๏ธ0
SmellMyFinger SmellMyFinger 2 weeks ago
It wasn't me. As I indicated in post #85726, "Too many stocks have been lost lately after transitioning to that so-called expert market for me, personally, to endorse any of them in good faith." Ergo, I will never assist in any pumps. Let the company itself push the PPS higher organically or not at all.
๐Ÿ‘๏ธ0
resx18 resx18 2 weeks ago
Good Morning $CBDL
๐Ÿ‘๏ธ0
packerfan9 packerfan9 2 weeks ago
Smart. Only ones who ever did well here. traded in and out quickly. The ones who held all down big after dilution and r/s. Now more dilution. .
๐Ÿ‘๏ธ0
konshe konshe 2 weeks ago
I am sold out with profits Today I don't want my profits gone
๐Ÿ‘๏ธ0
packerfan9 packerfan9 2 weeks ago
Sure not here as they will sell another 4.5 billion shares. The revenues not much after years. So tiny vs billions in dilution. They will never sell enough CBD to justify it. They get rich selling shares. The traders that did well. From Nov 2020 until big increase in A/S in 2021. Been bad ever since.
๐Ÿ‘๏ธ0
packerfan9 packerfan9 2 weeks ago
Wrong. Just showing all the same dilution as before. I now a dilution scam when I see it. I have been right since early 2020 when they started selling billions of shares. Nothing has changed. Trading any stock timing. The problem here with massive dilution. Is nay thing else you lose. Every one holding before this r.s has a lost. I see all the same arguments now that I have for years. Rinse and repeat. I lost no money here. Sad so many fall for this scam again.
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
The big move will come on the Amazon news they said will be out soon
๐Ÿ‘๏ธ0
konshe konshe 2 weeks ago
down on the news What's the problem?
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
It suckโ€™s you got caught in their r/s. Some of the biggest runs happen post r/s. I donโ€™t know if theyโ€™ll dilute or not. But it could run again soon. Needs to fill the gaps first
๐Ÿ‘๏ธ0
packerfan9 packerfan9 2 weeks ago
Sure you keep thinking that. At these levels and how no one holding before r/s has a gain. After the r/s they increased a/s to 4.5 billion. The buys are filled by them. They did this before. Like you others said no increase. Wrong. Wait and see. Ignore the past here. CBD has been around for many years. Have you seen how small revenues are on the income statements? They get rich selling billions of shares over and over not CBD. Some just ignore the record here.
๐Ÿ‘๏ธ0
10thMountain 10thMountain 2 weeks ago
The o/s hasnโ€™t changed
๐Ÿ‘๏ธ0
MahinAgency MahinAgency 2 weeks ago
CBD Life Sciences Inc. (CBDL) is poised for significant growth as federal marijuana legalization approaches, reporting a 1405% revenue increase since early 2024. The company plans to capitalize on the $70 billion cannabis market with innovative products and strategic partnerships.
๐Ÿ‘๏ธ0
packerfan9 packerfan9 2 weeks ago
When they increase the a/s to 4.5 billion. They will sell them all. Same as every time before they increased the a/s. The sale are tiny. They get rich selling billions of shares again again. Even at these levels. No one who owned before the last RS has a gain. It will end up to sell them all at .00001. Not the first time it has.
๐Ÿ‘๏ธ0
stealofadeal stealofadeal 2 weeks ago
$CBDL More fake bullsh!t news to sell Regulation A shares.
๐Ÿ‘๏ธ0
RedSox04 RedSox04 2 weeks ago
Bottom in here gonna bounce 
๐Ÿ‘๏ธ0
MahinAgency MahinAgency 2 weeks ago
CBD Life Sciences Inc. (CBDL) has launched mushroom-infused gummies targeting energy, sleep, and sexual wellness, tapping into the $20 billion mushroom market projected to grow over 14% annually. This innovative product line positions CBDL for significant growth and increased shareholder value.
๐Ÿ‘๏ธ0
konshe konshe 2 weeks ago
Markets positive reaction could be delayed, PPS waiting for move up.
👍️ 1

Your Recent History

Delayed Upgrade Clock